Findings in COVID-19 Reported from Instituto de Salud Carlos III (Maintenance of Potent Cellular and Humoral Immune Responses in Long-Term Hemodialysis Patients after 1273-mRNA SARS-CoV-2 Vaccination)

Press/Media

Period28 Apr 2023

Media coverage

1

Media coverage